Bluebook
Diagnostics and Tools Blue Book November 2024
2024 - November: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Ambry Genetics was acquired by Tempus
- TA Associates announced its acquisition of Nexus AG
- Sirona Medical closed a $42MM Series A Financing, led by Greatpoint Investment, 8VC, and Avidity Partners